Nu Skin Enterprises Reports Third Quarter Earnings

Nu Skin reported Q3 2026 revenue of $311.0 million, down 14.6% year over year, with foreign exchange accounting for a 1.1% impact, or $3.9 million; revenue was within the company’s guidance range. EPS was $(0.02), or $0.10 excluding certain charges, versus $0.34 a year earlier. Customers fell 18% to 609,469, paid affiliates declined 10% to 116,449, and sales leaders decreased 13% to 26,995.

Analysis

The more important signal is channel contraction, not the revenue line landing within guidance: customers, paid affiliates and sales leaders all declined materially year over year. If these measures represent the active selling ecosystem, continued attrition can weaken recruiting, repeat purchasing and distributor productivity, making revenue harder to stabilize even if FX becomes less adverse. The small stated FX effect suggests currency is not the main explanation for the sales decline. Verify the company’s definitions and cohort trends before treating the counts as a direct leading indicator.

Near term, an in-range quarter may limit the immediate downside surprise, but the gap between reported and adjusted EPS makes the quality and recurrence of excluded charges important. Over the next 1–3 months, watch forward guidance, active-customer retention and whether sales-leader attrition moderates. Over 6–18 months, persistent channel shrinkage would raise the risk of a lower sustainable revenue base and pressure on operating leverage; direct-selling peers could benefit only if customers or sellers are actually switching rather than leaving the channel.

Contrarian angle: a weak quarter is not itself a short thesis if expectations already embed prolonged contraction or the stock is priced for distress; the article provides neither valuation nor market reaction. A reversal in seller retention or evidence that revenue per active participant is improving would challenge the bearish read.

Key Decisions for Investors

• Keep NUS underweight / avoid adding on the basis of this release alone. The operating indicators are weaker than the in-guidance revenue result, but valuation and positioning are needed before sizing an outright short.
• Treat a short in NUS as a conditional 1–3 month idea: require confirmation from weaker forward guidance or continued deterioration in customer and sales-leader metrics. Reassess if those measures stabilize or improve.
• For the next results, verify the definitions and trend in active customers, paid affiliates and sales leaders, plus the bridge between reported and adjusted EPS and whether excluded charges recur.
• Falsification: a stabilization in channel metrics alongside improving guidance would undermine the contraction thesis; a further decline in those metrics or a guidance reduction would strengthen it.